Skip to main content
. 2022 Nov 2;8(1):96–108. doi: 10.1016/j.ncrna.2022.10.004

Table 5.

Statistical analysis of the levels of the NEAT1, HOTAIR, and GAS5 regarding patients’ characteristics and some clinical data among patients of Acute CVS-HTN and acute non-CVS-HTN groups (Mann–Whitney-U test).

Parameters CVS-HTN (n = 91)
 CVS-NHTN (n = 90)
NEAT1
 HOTAIR
 GAS5
 NEAT1
HOTAIR
GAS5
Median (IQR) P Median (IQR) P Median (IQR) P Median (IQR) P Median (IQR) P Median (IQR) P
Sex F 3.78 (1.29–6.48) 0.76 0.13(0.05–1.06) 0.09 0.17(0.01–0.72) 0.16 3.15(0.83–6.45) 0.58 0.35(0.04–1.08) 0.11 0.26(0.03–0.79) 0.13
M 3.59 (1.35–7.35 0.14(0.04–0.81) 0.16(0.03–0.61) 3.05(0.96–7.05) 0.34(0.03–0.83) 0.24(0.04–1.01)
DM yes 4.37 (2.58–10.45) 0.03∗ 0.14(0.03–0.67) 0.06 0.11(0.02–0.77) 0.04∗ 5.01(2.01–10.45) 0.02∗ 0.31(0.05–1.03) 0.052 0.24(0.03–1.03) 0.06
no 2.01 (0.78–5.35) 0.12(0.04–1.03) 0.16(0.05–0.79) 3.25(0.98–6.55) 0.35(0.03–0.98) 0.26(0.02–0.98)
Smoking yes 3.68(1.45–7.21) 0.51 0.13(0.05–0.79) 0.11 0.16(0.03–0.82) 0.19 3.14(1.03–8.96) 0.63 0.34(0.03–1.02) 0.07 0.26(0.03–1.01) 0.09
no 3.59(1.05–8.06) 0.12(0.04–1.01) 0.17(0.01–1.06) 3.09(0.98–7.21) 0.33(0.04–0.89) 0.25(0.04–0.98)
H/O Stroke yes 5.33(3.04–8.95) 0.03∗ 0.11(0.02–0.69) 0.05∗ 0.15(0.03–0.79) 0.06 4.99(2.42–8.57) 0.04∗ 0.33(0.02–1.04) 0.09 0.24(0.02–1.03) 0.07
no 2.35(0.86–5.64) 0.18(0.04–1.05) 0.16(0.02–0.91) 2.09(0.97–5.08) 0.34(0.03–0.79) 0.26(0.03–0.98)
Atheros yes 3.75(2.54–9.07) 0.70 0.14(0.06–0.68) 0.17 0.16(0.03–0.88) 0.65 3.09(0.98–6.78) 0.62 0.34(0.05–0.91) 0.14 0.22(0.03–1.41) 0.13
no 3.49(1.55–7.24) 0.13(0.04–0.95) 0.16(0.02–0.57) 3.15(1.09–8.77) 0.33(0.04–1.03) 0.25(0.04–0.99)
Stenosis yes 4.02(1.55–7.33) 0.55 0.14(0.04–0.83) 0.06 0.15(0.04–0.71) 0.17 3.01(1.08–7.44) 0.43 0.37(0.03–0.82) 0.15 0.25(0.03–1.07) 0.09
no 3.44(1.88–10.14) 0.12(0.03–0.92) 0.17(0.02–0.64) 3.25(1.23–8.62 0.33(0.06–0.91) 0.24(0.04–0.097)
AF yes 3.77(1.35–8.02) 0.40 0.13(0.025–0.80) 0.06 0.16(0.03–0.95) 0.56 3.22(1.09–8.33) 0.79 0.35(0.06–0.92) 0.11 0.27(0.01–1.07) 0.06
no 3.29(1.02–9.01) 0.12(0.04–0.69) 0.16(0.04–0.62) 3.05(0.98–7.66) 0.34(0.03–0.88) 0.25(0.04–0.89)
IHD yes 3.59(1.32–7.99) 0.56 0.14(0.02–1.01) 0.09 0.17(0.03–0.77) 0.09 3.20(0.95–6.08) 0.38 0.36(0.03–0.86) 0.07 0.24(0.01–0.99) 0.23
no 3.45(1.41–8.67) 0.12(0.04–0.89) 0.16(0.04–0.93) 3.05(1.09–7.58) 0.33(0.04–0.79) 0.26(0.04–0.93)
RHD yes 3.71(1.29–8.74) 0.63 0.13(0.03–0.91) 0.07 0.16(0.02–1.05) 0.39 3.88(0.95–7.54) 0.75 0.35(0.03–0.97) 0.09 0.23(0.04–1.06) 0.16
No 3.45(1.33–9.25) 0.12(0.05–1.06) 0.17(0.03–0.81) 3.01(1.01–8.99) 0.34(0.03–0.73) 0.25(0.03–0.76)
VR Yes 3.25(2.55–8.10) 0.49 0.13(0.03–0.95) 0.13 0.15(0.01–0.71) 0.13 3.01(1.08–8.66) 0.68 0.35(0.03–0.89) 0.31 0.26(0.03–1.03) 0.07
No 3.69(1.33–7.55) 0.12(0.04–0.88) 0.14(0.02–0.61) 3.21(0.97–7.22) 0.34(0.03–0.81) 0.25(0.04–0.97)

DM, diabetes mellitus; H/O stroke, history of stroke; Atheros, atherosclerosis; AF, atrial fibrillation, IHD, ischemic heart diseases, RHD, rheumatic heart diseases; VR, valve replacement.